Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
11/19/2014 11/20/2014 11/21/2014 11/24/2014 11/25/2014 Date
9.17 9.07 9.13 9.04 9.07 Last
5200 3500 3840 4240 1600 Volume
-1.82% -1.09% +0.66% -0.99% +0.33% Change
Company
Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world.Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
Surperformance© rating of Cardiome Pharma Corp.
Trading Rating : Investor Rating :
More about the company
Chart CARDIOME PHARMA CORP.
Duration : Period :
Cardiome Pharma Corp. Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Financials ( CAD)
Sales 2014 36,0 M
EBIT 2014 -13,7 M
Net income 2014 -16,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 38,6 M
EBIT 2015 -12,5 M
Net income 2015 -15,4 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 4,15x
Capi. / Sales 2015 3,88x
Capitalization 150 M
More Financials
Latest news on CARDIOME PHARMA CORP.
11/17 CARDIOME PHARMA : Enters Commercialization Agreement With Aspen For Brinavess In..
11/17 CARDIOME PHARMA : Enters Commercialization Agreement with Aspen for BRINAVESS® i..
11/07 CARDIOME PHARMA : Reports Third Quarter 2014 Financial Results
11/07 CARDIOME PHARMA : Announces Positive Results from the BRINAVESS® Asia-Pacific Ph..
11/07 CARDIOME PHARMA : Submits BRINAVESS® Reimbursement Dossier to Italian Authoritie..
10/31 CARDIOME PHARMA : to Hold Third Quarter 2014 Financial Results Conference Call o..
08/25 CARDIOME PHARMA : Enters Commercialization Agreement With Eurolab Especialidades..
08/25 CARDIOME PHARMA : Enters Commercialization Agreement With Eurolab Especialidades..
08/11 CARDIOME PHARMA : Reports Second Quarter 2014 Financial Results
08/06 CARDIOME PHARMA : Submits BRINAVESS Dossier to French Authorities to Support Mar..
08/06 CARDIOME PHARMA : To Present At Canaccord Genuity Growth Conference On August 13
08/05 CARDIOME PHARMA : Submits BRINAVESS Reimbursement Dossier to Belgian Authorities
More news


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF